World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 117 4225 3958 126 115 654 47090

Piero Picci publications per year

The chart shows the history of publications by Piero Picci between 1979 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Piero Picci published across 47 years, from 1979 to 2025, averaging 17.4 papers a year. Output peaked at 158 publications in 2023. 2 of the 818 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1979 to 2025. Vertical axis: number of publications, 0 to 158. Peak 158 publications in 2023. 1979: 1 publication 1980: 1 publication 1981: 2 publications 1982: 3 publications 1983: 5 publications 1984: 1 publication 1985: 9 publications 1986: 10 publications 1987: 6 publications 1988: 11 publications 1989: 9 publications 1990: 7 publications 1991: 8 publications 1992: 9 publications 1993: 11 publications 1994: 6 publications 1995: 6 publications 1996: 13 publications 1997: 8 publications 1998: 16 publications 1999: 15 publications 2000: 18 publications 2001: 18 publications 2002: 11 publications 2003: 10 publications 2004: 20 publications 2005: 16 publications 2006: 19 publications 2007: 19 publications 2008: 10 publications 2009: 23 publications 2010: 22 publications 2011: 27 publications 2012: 31 publications 2013: 24 publications 2014: 42 publications 2015: 37 publications 2016: 31 publications 2017: 30 publications 2018: 39 publications 2019: 17 publications 2020: 18 publications 2021: 14 publications 2022: 5 publications 2023: 158 publications 2024: 0 publications 2025: 2 publications
1979 2025

818 publications in total across all disciplines

View publications per year as a table
Piero Picci: publications per year, 1979 to 2025
Year Publications
1979 1
1980 1
1981 2
1982 3
1983 5
1984 1
1985 9
1986 10
1987 6
1988 11
1989 9
1990 7
1991 8
1992 9
1993 11
1994 6
1995 6
1996 13
1997 8
1998 16
1999 15
2000 18
2001 18
2002 11
2003 10
2004 20
2005 16
2006 19
2007 19
2008 10
2009 23
2010 22
2011 27
2012 31
2013 24
2014 42
2015 37
2016 31
2017 30
2018 39
2019 17
2020 18
2021 14
2022 5
2023 158
2024 0
2025 2
Total 818
Download as CSV

Piero Picci publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Piero Picci sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 641–660 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 654 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371 654
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Piero Picci D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Piero Picci sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 116–117 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318 117
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Piero Picci is affiliated with the University of Bologna in Italy and has a primary focus in the field of medicine, with a significant contribution to pulmonary and respiratory medicine, rheumatology, neurology, oncology, and pathology and forensic medicine. Their research spans a range of clinical and pathological subjects, emphasizing tumor diagnosis and treatment.

The scientist's work frequently addresses topics related to:

  • Sarcoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Vascular Tumors and Angiosarcomas
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Cardiac tumors and thrombi

Piero Picci has contributed to multiple papers including:

  • Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups, 2020, Journal of Clinical Oncology
  • Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma, 2020, JAMA Oncology
  • Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial, 2021, Cancer
  • The sacral chordoma margin, 2020, European Journal of Surgical Oncology
  • Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab, 2021, BMC Cancer

The scientist's work has been published extensively in various venues, with highest frequency in:

  • Journal of Clinical Oncology
  • Cancers
  • Cancer
  • European Journal of Surgical Oncology
  • BMC Cancer

Frequent coauthors collaborating with Piero Picci include:

  • Emanuela Palmerini
  • Giovanni Grignani
  • Davide María Donati
  • Marco Gambarotti
  • Alessandra Longhi

The body of work reflects research concentrated on the challenges of diagnosis and treatment of soft tissue sarcomas and bone tumors, as well as addressing genetic susceptibilities in oncology patients. The collaboration network and publication history indicate active engagement with clinical trials and multidisciplinary research in tumor pathology and therapy.

Best Publications

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

    Sergio Frustaci;Franco Gherlinzoni;Antonino De Paoli;Marco Bonetti

  • Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.

    Gaetano Bacci;Alessandra Longhi;Michela Versari;Mario Mercuri

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Nathalie Gaspar;Douglas S. Hawkins;Uta Dirksen;Ian J. Lewis

  • Osteosarcoma (Osteogenic sarcoma)

    Piero Picci

  • Unicameral and aneurysmal bone cysts.

    Mario Campanacci;Rodolfo Capanna;Piero Picci

  • Platelet-derived growth factors enhance proliferation of human stromal stem cells.

    Enrico Lucarelli;Amira Beccheroni;Davide Donati;Luca Sangiorgi

  • Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

    Stefano Ferrari;Sigbjorn Smeland;Mario Mercuri;Franco Bertoni

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

    Gaetano Bacci;Stefano Ferrari;Franco Bertoni;Pietro Ruggieri

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • Chordoma of the mobile spine: fifty years of experience.

    Stefano Boriani;Stefano Bandiera;Roberto Biagini;Patrizia Bacchini

  • Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

    Nicola Baldini;Katia Scotlandi;Giovanni Barbanti-Bròdano;Maria Cristina Manara

  • The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation

    Andrew S. Brohl;David A. Solomon;Wendy Chang;Jianjun Wang

  • Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

    Gaetano Bacci;Piero Picci;Stefano Ferrari;Pietro Ruggieri M.D.

  • Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.

    P Picci;L Sangiorgi;B T Rougraff;J R Neff

  • A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

    G Grignani;Emanuela Palmerini;P. Dileo;S. D. Asaftei

  • Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

    Stefano Ferrari;Antonio Briccoli;Mario Mercuri;Franco Bertoni

  • Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution

    Emanuela Palmerini;Eric L. Staals;Marco Alberghini;Licciana Zanella

Frequent Co-Authors

Katia Scotlandi
Katia Scotlandi Wayne State University
Mario Mercuri
Mario Mercuri University of Bologna
Franco Bertoni
Franco Bertoni Ospedale San Donato
Paolo G. Casali
Paolo G. Casali University of Milan
Angelo Paolo Dei Tos
Angelo Paolo Dei Tos University of Padua
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Alessandro Gronchi
Alessandro Gronchi University of Milan
Nicola Baldini
Nicola Baldini University of Bologna
Sakari Knuutila
Sakari Knuutila University of Helsinki
David W. P. Thomas
David W. P. Thomas University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean attending medical school. There are several affordable online programs that offer alternative pathways into the healthcare field. For those drawn to health data, an online MHI (Master’s in Health Information) provides advanced skills in managing and analyzing medical information.

Medical billing and coding is a critical part of healthcare administration. If you’re curious about costs, find out how much is medical billing and coding school and explore affordable options that can help you start your career in this growing field.

Nurses looking to advance their practice can consider the cheapest FNP programs (Family Nurse Practitioner) or pursue an MSN. There are opportunities for aspiring nurses to find the cheapest online MSN programs and earn advanced credentials without the burden of high tuition.

These online options offer flexibility and accessibility, opening doors to various healthcare careers beyond the traditional path of becoming a physician.

Best Scientists Citing Piero Picci

Trending Scientists

Recently Published Articles